Another example on a different aspect of evolution: natural selection as a means to design.
9. FS Santiago, HC Lowe, MM Kavurma, CN Chesterman, A Baker, DG Atkins,LM Khachigian, New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nature Medicine 5:1264-1269, 1999.
Access : New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury : Nature Medicine
Journal of Clinical Investigation -- Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function
A common treatment for clogged arteries in the heart is balloon angioplasty. A deflated balloon is placed, via catheter, at the site where the artery is clogged. The balloon is inflated and this 1) widens the artery and 2) breaks up the clog. However, a major problem is that the cells inthe artery -- particularly the smooth muscle cells -- divide and proliferate and close off the artery again. This is called restenosis.
Egr-1 is a protein that causes the proliferation of the smooth muscle cells. Stop the Egr-1 and you stop restenosis. What the researchers wanted was something that would degrade either Egr-1 or the messenger RNA that codes for Egr-1. However, any enzyme that would chop up the protein Egr-1 or the mRNA is itself destroyed too quickly by the cell to have an effect. What was needed was something that the cell would not degrade.
There are RNA molecules that are also enzymes. They are called ribozymes. There are hundreds/thousands of ribozymes in nature. But there are no DNA molecules in nature that are also enzymes. In this case, tho, a DNA enzyme is what they wanted because, not being in nature, the cell would not have any enzymes that would degrade it. So a DNA enzyme would stick around a long time.
But how to make one? What specific sequence nucleotides would be needed to make a DNA enzyme that would cleave the mRNA for Egr-1? The researches didn't have a clue. A DNA synthesizer can be used to make DNA molecules. They add one nucleotide at a time and the operator knows which nucleotide he is adding, so he knows the sequence. But that didn't help because they didn't know what sequence would cleave Egr-1 mRNA.
So they let natural selection make one. They started out with a million
random DNA molecules. They tested these to see if any of them had even the
tiniest enzyme activity toward Egr-1 mRNA. They found about 100 that had barely detectable activity. They selected these and then had them randomly mutated and proliferated to make the next generation. Tested this generation for activity. Those that had a bit better activity than the previous generation they kept (selected). You can see what is happening here: the humans set the environment. But it is natural selection that is making the activity to cleave Egr-1 mRNA.
After 10 generations, one of the DNA enzymes had an activity comparable to the naturally occurring enzyme ribonuclease A.
Only
after this point did the researchers sequence the DNA in order to try to figure out how it worked. That also shows that they were not the "designers". After all, a watchmaker knows how the watch works before he puts it together; these guys did not know what the parts were until after natural selection had designed it.
This particular DNA enzyme is now in clinical trials. Other DNA enzymes -- also made by natural selection for different targets -- also also in clinical trials.